Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation

Guangya Zhu(Chinese Academy of Sciences), Jidong Zhu(Regend Therapeutics (China)), Youqi Tao(Shanghai Jiao Tong University), Zhenying Liu(China Academy of Chinese Medical Sciences), Zhihong Yu(Purdue University West Lafayette), Jingjing Xie(Chinese Academy of Sciences), Jingfei Xie(Chinese Academy of Sciences), Lin Sun(Shanghai Institute of Materia Medica), Qiangang Zheng, Tianxin Zhu(Shanghai Institute of Organic Chemistry), Hong C. Shen(Southern Medical University), Wenna Kong(Chinese Academy of Sciences), Cong Liu(Chinese Academy of Sciences), Dan Li(Shanghai Jiao Tong University), Yichen Li(Sichuan University), Siying Wang(Anhui Medical University), Xi Xia(Chinese Academy of Sciences), Zhong‐Yin Zhang(Purdue University West Lafayette), Kan Chen(Zhejiang Sci-Tech University), Lin Du(The University of Western Australia), Mingfeng Guan(Chinese Academy of Sciences), Yongguo Yu(Shanghai Jiao Tong University), Huan Li(Kunming University of Science and Technology), Hao He(Chinese Academy of Sciences)
Cell
September 30, 2020
Cited by 274


Related Papers